Skip to content

Pro-Change Smoking Cessation Intervention

Software to Translate Behavioral Economics Insights to Improve Health (Phase 2b)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02299076
Enrollment
422
Registered
2014-11-24
Start date
2016-01-01
Completion date
2016-07-01
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motivation, Tobacco Smoking Cessation

Keywords

Tobacco smoking cessation, Motivation

Brief summary

The purpose of this study is to determine whether a behavioral economics solution impacts smoking cessation program engagement and quit rates.

Detailed description

The behavioral economics solution is a weekly regret contest in which participants can win or miss out on money based on their behavior.

Interventions

BEHAVIORALBehavioral economics incentives

Behavioral economics-informed incentives to promote engagement and outcomes in a smoking cessation intervention.

OTHERMinimal incentives

Minimal financial incentives to promote engagement and outcomes in a smoking cessation intervention.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Rhode Island Primary Care Physicians Corporation
CollaboratorUNKNOWN
Pro-Change Behavior Systems
CollaboratorOTHER
VAL Health, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be current tobacco users (specifically smokers) * Be 18 years old or over

Exclusion criteria

* Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Average Number of Completed Sessions Per ParticipantEvery 30 days for up to 6 months post-enrollmentEngagement rates for the intervention will be higher relative to the control arm. Engagement is measured by the number of complete tobacco cessation sessions per participant.
Outcome of Smoking Cessation InterventionEvery 30 days for up to 6 months post-enrollmentQuit levels for the intervention will be higher relative to the control arm. Quit level is defined as a participant who progresses to the stage in the tobacco cessation program where they quit smoking. The quit stages are levels 4 and 5 of the tobacco cessation program.

Countries

United States

Participant flow

Recruitment details

Recruitment period: January to March, 2016. Recruitment methods: Physician and nurse referrals from Rhode Island Primary Care Physicians Corporation and Facebook advertisements. Intake method: Digital intake form hosted by Pro-Change.

Pre-assignment details

We identified and discontinued 34 participants whose accounts were were flagged as being suspicious. Duplicate accounts were erroneously created by a participant and thus were removed from the study. Suspicious accounts contained personal information identical to existing participants and after investigation, were concluded to be fraudulent.

Participants by arm

ArmCount
Usual Care With Minimal Incentives
Participants in this arm receive usual care from the Pro-Change smoking cessation program, and receive compensation for enrolling and completing a survey at the end of the study. Minimal incentives: Minimal financial incentives to promote engagement, and outcomes in a smoking cessation intervention.
210
Usual Care With BE Incentives
Participants in this arm receive usual care from the Pro-Change smoking cessation program, the chance to win money based on their behavior (Behavioral economics incentives), and receive compensation for enrolling and completing a survey at the end of the study. Behavioral economics incentives: Behavioral economics-informed incentives to promote engagement and outcomes in a smoking cessation intervention.
212
Total422

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyFraudulent Entries2014

Baseline characteristics

CharacteristicUsual Care With Minimal IncentivesUsual Care With BE IncentivesTotal
Age, Continuous44 years44 years44 years
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants18 Participants27 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
196 Participants188 Participants384 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants6 Participants11 Participants
Region of Enrollment
United States
210 Participants212 Participants422 Participants
Sex: Female, Male
Female
138 Participants150 Participants288 Participants
Sex: Female, Male
Male
72 Participants62 Participants134 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2100 / 212
other
Total, other adverse events
0 / 2100 / 212
serious
Total, serious adverse events
0 / 2100 / 212

Outcome results

Primary

Average Number of Completed Sessions Per Participant

Engagement rates for the intervention will be higher relative to the control arm. Engagement is measured by the number of complete tobacco cessation sessions per participant.

Time frame: Every 30 days for up to 6 months post-enrollment

ArmMeasureValue (MEAN)
Usual Care With Minimal IncentivesAverage Number of Completed Sessions Per Participant1.633 Average Number of Sessions
Usual Care With BE IncentivesAverage Number of Completed Sessions Per Participant3.052 Average Number of Sessions
p-value: <0.0001t-test, 2 sided
Primary

Outcome of Smoking Cessation Intervention

Quit levels for the intervention will be higher relative to the control arm. Quit level is defined as a participant who progresses to the stage in the tobacco cessation program where they quit smoking. The quit stages are levels 4 and 5 of the tobacco cessation program.

Time frame: Every 30 days for up to 6 months post-enrollment

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual Care With Minimal IncentivesOutcome of Smoking Cessation Intervention38 Participants
Usual Care With BE IncentivesOutcome of Smoking Cessation Intervention63 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026